BOULDER, Colo., May 06, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical ...

Good day, everyone, and welcome to the Williams First Quarter 2025 Earnings Conference Call. Today's conference is being recorded. At this time, for opening remarks and introductions, I would like to ...

ActiveCampaign, a leading marketing automation platform, has named Simon Malkowski as its new Chief Operating Officer. Malkowski will lead company-wide efforts to deepen alignment, drive operational ...

Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / ...

Continued progress in the PIKture-01 trial; on track to report additional data in the second half of 2025, including mature single agent and initial combination data -- Expansion of the Company's ...

Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsEmily Epstein - General CounselStan Chia ...

These products are used in the company’s specialized end products or sold externally. Celanese produces these commodity chemicals in its acetyl chain segment, which generates around half of ...

The Moodie Davitt Report is delighted to present the results of the inaugural TREX Awards. A trailblazing celebration of the finest travel retail-exclusive products and other initiatives, the TREX ...

SolarBank Corporation (Cboe CA: SUNN) ("SolarBank" or the "Company") announced today that CIM Group ("CIM"), a real estate and infrastructure owner, operator, lender and developer, and the Company ...

Two biosimilars developed under the Teva - Alvotech partnership have been granted FDA approval with interchangeability, including SELARSDI. In February 2024, the FDA approved SIMLANDI ® ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a business ...

ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today reported financial results for the first quarter ended March 31, 2025, and provided a business update.